Your browser doesn't support javascript.
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Alaggio, Rita; Amador, Catalina; Anagnostopoulos, Ioannis; Attygalle, Ayoma D; Araujo, Iguaracyra Barreto de Oliveira; Berti, Emilio; Bhagat, Govind; Borges, Anita Maria; Boyer, Daniel; Calaminici, Mariarita; Chadburn, Amy; Chan, John K C; Cheuk, Wah; Chng, Wee-Joo; Choi, John K; Chuang, Shih-Sung; Coupland, Sarah E; Czader, Magdalena; Dave, Sandeep S; de Jong, Daphne; Du, Ming-Qing; Elenitoba-Johnson, Kojo S; Ferry, Judith; Geyer, Julia; Gratzinger, Dita; Guitart, Joan; Gujral, Sumeet; Harris, Marian; Harrison, Christine J; Hartmann, Sylvia; Hochhaus, Andreas; Jansen, Patty M; Karube, Kennosuke; Kempf, Werner; Khoury, Joseph; Kimura, Hiroshi; Klapper, Wolfram; Kovach, Alexandra E; Kumar, Shaji; Lazar, Alexander J; Lazzi, Stefano; Leoncini, Lorenzo; Leung, Nelson; Leventaki, Vasiliki; Li, Xiao-Qiu; Lim, Megan S; Liu, Wei-Ping; Louissaint, Abner; Marcogliese, Andrea; Medeiros, L Jeffrey.
  • Alaggio R; Pathology Unit, Department of Laboratories, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • Amador C; Department of Pathology, University of Miami, Miami, FL, USA.
  • Anagnostopoulos I; Institute of Pathology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
  • Attygalle AD; Department of Histopathology, Royal Marsden Hospital, London, UK.
  • Araujo IBO; Department of Pathology, Federal University of Bahia (UFBA), Salvador, Brazil.
  • Berti E; University of Milan, Fondazione Cà Granda, IRCCS, Ospedale Maggiore Policlinico, Milan, Italy.
  • Bhagat G; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA.
  • Borges AM; Division of Histopathology, SL Raheja Hospital, Mumbai, India.
  • Boyer D; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Calaminici M; Centre for Haemato-Oncology, Barts Cancer institute, QMUL and SIHMDS Barts Health NHS Trust, London, UK.
  • Chadburn A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Chan JKC; Department of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong.
  • Cheuk W; Department of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong.
  • Chng WJ; National University Cancer Institute, Singapore, Singapore.
  • Choi JK; Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA.
  • Chuang SS; Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan.
  • Coupland SE; Liverpool Clinical Laboratories, Liverpool University Hospitals Foundation Trust, Liverpool, UK.
  • Czader M; Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN, USA.
  • Dave SS; Center for Genomic and Computational Biology and Department of Medicine, Duke University, Durham, NC, USA.
  • de Jong D; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pathology, Amsterdam, The Netherlands.
  • Du MQ; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK. mqd20@cam.ac.uk.
  • Elenitoba-Johnson KS; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Ferry J; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. JFERRY@mgh.harvard.edu.
  • Geyer J; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Gratzinger D; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Guitart J; Department. of Dermatology, Northwestern University Feinberg Medical School, Chicago, IL, USA.
  • Gujral S; Department of Pathology, Tata Memorial Hospital, Mumbai, India.
  • Harris M; Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
  • Harrison CJ; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle-upon-Tyne, UK.
  • Hartmann S; Dr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Hochhaus A; Hematology/Oncology, Universitätsklinikum Jena, Jena, Germany.
  • Jansen PM; Leiden University Medical Center, Department of Pathology, Leiden, The Netherlands.
  • Karube K; Department of Pathology and Laboratory Medicine, Nagoya, Japan.
  • Kempf W; Kempf und Pfaltz Histologische Diagnostik Zurich, and Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Khoury J; Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kimura H; Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Klapper W; Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
  • Kovach AE; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Kumar S; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Lazar AJ; Departments of Pathology & Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lazzi S; Department of Medical Biotechnology, University of Siena, Siena, Italy.
  • Leoncini L; Department of Medical Biotechnology, University of Siena, Siena, Italy.
  • Leung N; Division of Nephrology and Hypertension, Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Leventaki V; Department of Pathology, Medical College of Wisconsin and Children's Wisconsin, Milwaukee, WI, USA.
  • Li XQ; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Lim MS; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Liu WP; Department of Pathology, West-China Hospital, Sichuan University, Chengdu, China.
  • Louissaint A; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Marcogliese A; Department of Pathology & Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
  • Medeiros LJ; Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Leukemia ; 36(7): 1720-1748, 2022 07.
Article in English | MEDLINE | ID: covidwho-1972568
ABSTRACT
We herein present an overview of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / Lymphoma Limits: Humans Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2022 Document Type: Article Affiliation country: S41375-022-01620-2

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / Lymphoma Limits: Humans Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2022 Document Type: Article Affiliation country: S41375-022-01620-2